| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |